340B

Hospitals Rachel Cohrs

STAT Plus: HHS will decide how to resolve $1 billion in payments for 340B hospitals

First Opinion John Michael O'Brien

After 30 years of 340B, it’s time for data and an honest conversation

Pharmalot Ed Silverman

STAT Plus: U.S. bid to force drug makers to offer discounts to some hospitals was ‘arbitrary and capricious,’ judge rules

Pharmalot Ed Silverman

STAT Plus: Federal officials move closer to penalizing drug makers for failing to offer discounts to safety-net hospitals

Pharmalot Ed Silverman

STAT Plus: Safety-net hospitals take big markups on cancer drugs for commercially insured patients, study finds

Politics Rachel Cohrs

Virtual Event: The 340B drug discount program is at a crossroads. What’s next?